Heparan sulphate epitope-expression is associated with the inflammatory response in metastatic malignant melanoma

Cancer Immunology, Immunotherapy

Volumn 52, Issue 12, 2003, Pages 780-783

  Bernsen, Monique R ^a,b   Smetsers, Toon F C M ^b   Van De Westerlo, Els ^b   Ruiter, Dirk J ^b   Håkansson, Leif ^a   Gustafsson, Bertil ^a   Van Kuppevelt, Toin H ^b   Krysander, Lennart ^a   Rettrup, Björn ^c   Håkansson, Annika ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c KALMAR COUNTY HOSPITAL   (Sweden)

Author keywords

Heparan sulphate; Melanoma; T cell recruitment inflammation

Indexed keywords

CD3 ANTIGEN; EPITOPE; HEPARAN SULFATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY EW4G1; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; CELL INFILTRATION; CELL MEMBRANE; CELL MIGRATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; EPITOPE MAPPING; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MELANOMA; MOLECULAR BIOLOGY; MOLECULAR CLONING; PATHOLOGICAL ANATOMY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN METASTASIS; STAINING; STRUCTURE ACTIVITY RELATION;

ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGENS, CD3; EPITOPES; HEPARITIN SULFATE; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; PEPTIDE FRAGMENTS; PILOT PROJECTS; SKIN NEOPLASMS;

EID: 10744228305     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-003-0421-8     Document Type: Article

References (14)

1. Caux F, Timar J, Lapis K, Moczar M (1990) Proteochondroitin sulphate in human melanoma cell cultures. Biochem Soc Trans 18:293
2. Ey PL, Prowse SJ, Jenkin CR (1978) Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry 15:429
3. Hershkoviz R, Schor H, Ariel A, Hecht I, Cohen IR, Lider O, Cahalon L (2000) Disaccharides generated from heparan sulphate or heparin modulate chemokine-induced T-cell adhesion to extracellular matrix. Immunology 99:87
4. Kato M, Wang H, Bernfield M, Gallagher JT, Turnbull JE (1994) Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains. J Biol Chem 269:18881
5. Lindahl U, Kusche-Gullberg M, Kjellen L (1998) Regulated diversity of heparan sulfate. J Biol Chem 273:24979
6. Lortat-Jacob H, Grimaud JA (1991) Interferon-gamma C-terminal function: new working hypothesis. Heparan sulfate and heparin, new targets for IFN-gamma, protect, relax the cytokine and regulate its activity. Cell Mol Biol 37:253
7. Moczar M, Caux F, Bailly M, Berthier O, Dore JF (1993) Accumulation of heparan sulfate in the culture of human melanoma cells with different metastatic ability. Clin Exp Metastasis 11:462
8. Nathan C, Sporn M (1991) Cytokines in context. J Cell Biol 113:981
9. Salmivirta M, Lidholt K, Lindahl U (1996) Heparan sulfate: a piece of information. FASEB J 10:1270
10. Selvan RS, Ihrcke NS, Platt JL (1996) Heparan sulfate in immune responses. Ann N Y Acad Sci 797:127
11. Turnbull JE, Fernig DG, Ke Y, Wilkinson MC, Gallagher JT (1992) Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J Biol Chem 267:10337
12. van de Westerlo EM, Smetsers TF, Dennissen MA, Linhardt RJ, Veerkamp JH, van Muijen GN, van Kuppevelt TH (2002) Human single chain antibodies against heparin: selection, characterization, and effect on coagulation. Blood 99:2427
13. van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH (1998) Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology: further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem 273:12960
14. Vlodavsky I, Korner G, Ishai-Michaeli R, Bashkin P, Bar-Shavit R, Fuks Z (1990) Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev 9:203